Accurate risk assessment improves results for health plans across a multitude of areas, including member care, quality metrics, and risk adjustment programs. Cotiviti CEO Emad Rizk, M.D. joined Tuning In to the C-Suite, a Managed Healthcare Executive podcast, to discuss how payers can improve their risk assessment with tools that enable them to have a unified view of numerous data types, including claims, clinical, pharmacy, lab results, and social determinants of health (SDoH).
"One of the things I try to emphasize to the industry is that we should always focus on social determinants of health, we should focus on risk, quality, and cost—all of those things are important. But what's even more important are the interdependencies of all of them.
Tune in to the podcast as he discusses:
- How the COVID-19 pandemic illustrated the lack of interoperability in healthcare
- How healthcare outcomes are influenced by SDoH
- How tools such as Cotiviti's DxCG Intelligence predict member risk and cost
The foundational role of accurate risk assessment has been recognized for decades, with risk adjustment and predictive modeling serving as cornerstones of modern value-based healthcare. Read our white paper and learn about the history of Cotiviti's DxCG Intelligence, one of the earliest and most accurate risk assessment and predictive modeling solutions in healthcare.
